These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

556 related articles for article (PubMed ID: 28142149)

  • 21. Evolving Strategies for Therapeutically Targeting Cancer Stem Cells.
    Talukdar S; Emdad L; Das SK; Sarkar D; Fisher PB
    Adv Cancer Res; 2016; 131():159-91. PubMed ID: 27451127
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Role of Cancer Stem Cells in Recurrent and Drug-Resistant Lung Cancer.
    Suresh R; Ali S; Ahmad A; Philip PA; Sarkar FH
    Adv Exp Med Biol; 2016; 890():57-74. PubMed ID: 26703799
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prostate cancer stem cell biology.
    Yu C; Yao Z; Jiang Y; Keller ET
    Minerva Urol Nefrol; 2012 Mar; 64(1):19-33. PubMed ID: 22402315
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Targeting autophagy in cancer stem cells as an anticancer therapy.
    Lei Y; Zhang D; Yu J; Dong H; Zhang J; Yang S
    Cancer Lett; 2017 May; 393():33-39. PubMed ID: 28216370
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Targeting prostate cancer stem cells.
    Crea F; Mathews LA; Farrar WL; Hurt EM
    Anticancer Agents Med Chem; 2009 Dec; 9(10):1105-13. PubMed ID: 19925394
    [TBL] [Abstract][Full Text] [Related]  

  • 26. At the crossroads of cancer stem cells and targeted therapy resistance.
    Wang A; Qu L; Wang L
    Cancer Lett; 2017 Jan; 385():87-96. PubMed ID: 27816488
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cancer stem cell targeted therapy: progress amid controversies.
    Wang T; Shigdar S; Gantier MP; Hou Y; Wang L; Li Y; Shamaileh HA; Yin W; Zhou SF; Zhao X; Duan W
    Oncotarget; 2015 Dec; 6(42):44191-206. PubMed ID: 26496035
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Androgen receptor and prostate cancer stem cells: biological mechanisms and clinical implications.
    Deng Q; Tang DG
    Endocr Relat Cancer; 2015 Dec; 22(6):T209-20. PubMed ID: 26285606
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical significance of epithelial-mesenchymal transition and cancer stem cells.
    Topcul M; Cetin I
    J BUON; 2016; 21(2):312-9. PubMed ID: 27273939
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Exosomes from bulk and stem cells from human prostate cancer have a differential microRNA content that contributes cooperatively over local and pre-metastatic niche.
    Sánchez CA; Andahur EI; Valenzuela R; Castellón EA; Fullá JA; Ramos CG; Triviño JC
    Oncotarget; 2016 Jan; 7(4):3993-4008. PubMed ID: 26675257
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Isolation, identification, and characterization of cancer stem cells: A review.
    Abbaszadegan MR; Bagheri V; Razavi MS; Momtazi AA; Sahebkar A; Gholamin M
    J Cell Physiol; 2017 Aug; 232(8):2008-2018. PubMed ID: 28019667
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Targeting cancer stem-like cells in glioblastoma and colorectal cancer through metabolic pathways.
    Kahlert UD; Mooney SM; Natsumeda M; Steiger HJ; Maciaczyk J
    Int J Cancer; 2017 Jan; 140(1):10-22. PubMed ID: 27389307
    [TBL] [Abstract][Full Text] [Related]  

  • 33. DNMT1 Regulates Epithelial-Mesenchymal Transition and Cancer Stem Cells, Which Promotes Prostate Cancer Metastasis.
    Lee E; Wang J; Yumoto K; Jung Y; Cackowski FC; Decker AM; Li Y; Franceschi RT; Pienta KJ; Taichman RS
    Neoplasia; 2016 Sep; 18(9):553-66. PubMed ID: 27659015
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Targeting Cancer Stem Cells in Castration-Resistant Prostate Cancer.
    Yun EJ; Zhou J; Lin CJ; Hernandez E; Fazli L; Gleave M; Hsieh JT
    Clin Cancer Res; 2016 Feb; 22(3):670-9. PubMed ID: 26490309
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification, characterization, and biological relevance of prostate cancer stem cells from clinical specimens.
    Kasper S
    Urol Oncol; 2009; 27(3):301-3. PubMed ID: 19414117
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cancer stem cells in colorectal cancer from pathogenesis to therapy: controversies and perspectives.
    Fanali C; Lucchetti D; Farina M; Corbi M; Cufino V; Cittadini A; Sgambato A
    World J Gastroenterol; 2014 Jan; 20(4):923-42. PubMed ID: 24574766
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Therapeutic Effectiveness of Anticancer Phytochemicals on Cancer Stem Cells.
    Oh J; Hlatky L; Jeong YS; Kim D
    Toxins (Basel); 2016 Jun; 8(7):. PubMed ID: 27376325
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ovarian cancer stem cell: A potential therapeutic target for overcoming multidrug resistance.
    Mihanfar A; Aghazadeh Attari J; Mohebbi I; Majidinia M; Kaviani M; Yousefi M; Yousefi B
    J Cell Physiol; 2019 Apr; 234(4):3238-3253. PubMed ID: 30317560
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Overexpression of secretory phospholipase A2-IIa supports cancer stem cell phenotype via HER/ERBB-elicited signaling in lung and prostate cancer cells.
    Lu S; Dong Z
    Int J Oncol; 2017 Jun; 50(6):2113-2122. PubMed ID: 28440478
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The natural flavonoid apigenin sensitizes human CD44
    Erdogan S; Turkekul K; Serttas R; Erdogan Z
    Biomed Pharmacother; 2017 Apr; 88():210-217. PubMed ID: 28107698
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.